Changgong Lan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Changgong Lan has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Changshuai Qin
Graduate School of Youjiang Medical University for Nationalities Baise Guangxi China
4 shared publicationsChengyi Qin
Graduate School of Youjiang Medical University for Nationalities Baise Guangxi China
3 shared publicationsCheng Huang
Graduate School of Youjiang Medical University for Nationalities Baise Guangxi China
2 shared publications- Cong Cao
Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, China
2 shared publications - Jin Yao
The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China
2 shared publications Wu Chen
Department of Neurosurgery, The Peoples Hospital of Baise, Baise 533009, China
2 shared publications
Latest Publications
- Open Access
- 30 December 2024
- Published by Elsevier in Regenerative Therapy
- Vol. 28, 235-245
Novel preparation of laponite based theranostic silver nanocomposite for drug delivery, radical scavenging and healing efficiency for wound care management after surgery
- 30 December 2024
- Published by Elsevier in Regenerative Therapy
- Vol. 28, 235-245
Open AccessNovel preparation of laponite based theranostic silver nanocomposite for drug delivery, radical scavenging and healing efficiency for wound care management after surgery
- Open Access
- 29 December 2024
- Published by Darcy & Roy Press Co. Ltd. in International Journal of Biology and Life Sciences
- Vol. 8 (3) , 16-21
Strategies for Constructing Osteosarcoma 3D Culture Models and Progress in Their Applications
Osteosarcoma is a highly malignant primary bone tumor, and traditional two-dimensional (2D) culture methods cannot accurately simulate the tumor microenvironment. Three-dimensional (3D) culture better simulates the in vivo tumor microenvironment, providing more realistic experimental data regarding tumor progression, drug resistance, and drug screening. This paper introduces various 3D culture technologies, including scaffold-free culture, scaffold-based culture, microfluidic chips, and bioprinting. Moreover, 3D models show significant advantages in tumor microenvironment simulation, drug screening, and research on osteoblasts and osteoclasts, thus promoting the development of personalized therapy. Overall, 3D culture offers an important tool and platform for a deeper understanding of osteosarcoma's biological mechanisms and improving clinical treatment outcomes.
- 29 December 2024
- Published by Darcy & Roy Press Co. Ltd. in International Journal of Biology and Life Sciences
- Vol. 8 (3) , 16-21
Open AccessStrategies for Constructing Osteosarcoma 3D Culture Models and Progress in Their Applications
Osteosarcoma is a highly malignant primary bone tumor, and traditional two-dimensional (2D) culture methods cannot accurately simulate the tumor microenvironment. Three-dimensional (3D) culture better simulates the in vivo tumor microenvironment, providing more realistic experimental data regarding tumor progression, drug resistance, and drug screening. This paper introduces various 3D culture technologies, including scaffold-free culture, scaffold-based culture, microfluidic chips, and bioprinting. Moreover, 3D models show significant advantages in tumor microenvironment simulation, drug screening, and research on osteoblasts and osteoclasts, thus promoting the development of personalized therapy. Overall, 3D culture offers an important tool and platform for a deeper understanding of osteosarcoma's biological mechanisms and improving clinical treatment outcomes.
- Retracted
- 9 December 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 287, 138537
Role of miRNA regulation in IGFBP-2 overexpression and neuronal ferroptosis: Insights into the Nrf2/SLC7A11/GPX4 pathway in Alzheimer's disease
- 9 December 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 287, 138537
RetractedRole of miRNA regulation in IGFBP-2 overexpression and neuronal ferroptosis: Insights into the Nrf2/SLC7A11/GPX4 pathway in Alzheimer's disease
- Open Access
- 22 November 2024
- Published by Darcy & Roy Press Co. Ltd. in International Journal of Biology and Life Sciences
- Vol. 8 (1) , 5-9
Study on Healing Treatment of Chronic Wound
Chronic wound is one of the difficulties in clinical treatment. The complex pathological mechanism of chronic wound involves many links, such as inflammation disorder, cell proliferation obstruction, insufficient angiogenesis and abnormal matrix remodeling. In recent years, with the rapid development of molecular biology, regenerative medicine and materials science, researchers have made remarkable breakthroughs in the molecular regulation of wound healing, the application of growth factors and new biological dressings. These advances not only deepen the understanding of the mechanism of chronic wound formation and extension, but also provide theoretical basis and technical support for the study of more effective and safe treatment strategies. In the future, further optimization of treatment strategies to promote rapid and functional wound healing will be the focus of research in this field. The purpose of this paper is to summarize the current research on chronic wound healing treatment, provide clinicians with theoretical and practical guidance on chronic wound treatment, and provide valuable reference for future research direction exploration and expansion.
- 22 November 2024
- Published by Darcy & Roy Press Co. Ltd. in International Journal of Biology and Life Sciences
- Vol. 8 (1) , 5-9
Open AccessStudy on Healing Treatment of Chronic Wound
Chronic wound is one of the difficulties in clinical treatment. The complex pathological mechanism of chronic wound involves many links, such as inflammation disorder, cell proliferation obstruction, insufficient angiogenesis and abnormal matrix remodeling. In recent years, with the rapid development of molecular biology, regenerative medicine and materials science, researchers have made remarkable breakthroughs in the molecular regulation of wound healing, the application of growth factors and new biological dressings. These advances not only deepen the understanding of the mechanism of chronic wound formation and extension, but also provide theoretical basis and technical support for the study of more effective and safe treatment strategies. In the future, further optimization of treatment strategies to promote rapid and functional wound healing will be the focus of research in this field. The purpose of this paper is to summarize the current research on chronic wound healing treatment, provide clinicians with theoretical and practical guidance on chronic wound treatment, and provide valuable reference for future research direction exploration and expansion.
- Open Access
- 30 October 2024
- Published by Darcy & Roy Press Co. Ltd. in International Journal of Biology and Life Sciences
- Vol. 7 (3) , 31-34
Research Progress of COL5A1 in Osteosarcoma
COL5A1 (Collagen V alpha 1 chain) has gained significant attention as an important component of the extracellular matrix in recent osteosarcoma research. This review aims to summarize the expression characteristics, functional mechanisms, and potential clinical applications of COL5A1 in the context of osteosarcoma. By examining the latest findings, we delve into the role of COL5A1 in promoting osteosarcoma cell proliferation, migration, and invasion, while also assessing its potential as a biomarker and therapeutic target. Through this comprehensive analysis, we hope to provide valuable insights that can guide future research and clinical applications in this crucial area of oncology.
- 30 October 2024
- Published by Darcy & Roy Press Co. Ltd. in International Journal of Biology and Life Sciences
- Vol. 7 (3) , 31-34
Open AccessResearch Progress of COL5A1 in Osteosarcoma
COL5A1 (Collagen V alpha 1 chain) has gained significant attention as an important component of the extracellular matrix in recent osteosarcoma research. This review aims to summarize the expression characteristics, functional mechanisms, and potential clinical applications of COL5A1 in the context of osteosarcoma. By examining the latest findings, we delve into the role of COL5A1 in promoting osteosarcoma cell proliferation, migration, and invasion, while also assessing its potential as a biomarker and therapeutic target. Through this comprehensive analysis, we hope to provide valuable insights that can guide future research and clinical applications in this crucial area of oncology.
- Open Access
- 26 July 2024
- Published by Elsevier in SLAS Technology
- Vol. 29 (4) , 100172
Optical imaging detection of extracellular vesicles of miR-146 modified bone marrow mesenchymal stem cells promoting spinal cord injury repair
- 26 July 2024
- Published by Elsevier in SLAS Technology
- Vol. 29 (4) , 100172
Open AccessOptical imaging detection of extracellular vesicles of miR-146 modified bone marrow mesenchymal stem cells promoting spinal cord injury repair
- Open Access
- 14 May 2024
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 15 (11) , 858-865
Syn3, a newly developed cyclic peptide and BDNF signaling enhancer, ameliorates retinal ganglion cell degeneration in diabetic retinopathy
Dear Editor,
- 14 May 2024
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 15 (11) , 858-865
Open AccessSyn3, a newly developed cyclic peptide and BDNF signaling enhancer, ameliorates retinal ganglion cell degeneration in diabetic retinopathy
Dear Editor,
- Open Access
- 1 January 2024
- Published by Ivyspring International Publisher in Theranostics
- Vol. 14 (5) , 2190-2209
G protein subunit alpha i2's pivotal role in angiogenesis
Here we explored the potential role of Gαi2 (G protein subunit alpha i2) in endothelial cell function and angiogenesis.
- 1 January 2024
- Published by Ivyspring International Publisher in Theranostics
- Vol. 14 (5) , 2190-2209
Open AccessG protein subunit alpha i2's pivotal role in angiogenesis
Here we explored the potential role of Gαi2 (G protein subunit alpha i2) in endothelial cell function and angiogenesis.
- Open Access
- 11 December 2023
- Published by Darcy & Roy Press Co. Ltd. in International Journal of Biology and Life Sciences
- Vol. 4 (2) , 7-13
Genes Such as IRS2 Differ from Ewing Sarcoma and Normal Tissue-specific Expression for Osteosarcoma
Objective: To screen and validate the expression of other key genes specific to osteosarcoma that distinguish normal tissue from Ewing sarcoma using a bioinformatics approach. Methods: GSE73166 for osteosarcoma associated with Ewing sarcoma and GSE42352 for osteosarcoma associated with normal tissue were obtained from the GEO database, and these two datasets were screened for differential genes (DEGs) and subjected to corresponding GO enrichment and KEGG enrichment with GSEA validation, and then correlation analysis, PCA and immuno-infiltration analysis were performed on the two datasets, and the These two datasets were intersected to derive 28 differential genes, and the corresponding heat map analysis and protein interaction network analysis were performed for these 28 genes, and then the expression statistics of these 28 genes in GSE21257 for different graded genes and survival analysis in R2 for osteosarcoma in TARGET. Results: TNFRSF11B, COL12A1, PLOD2, PTGES, MEF2C, IRS2 and MMP13 were found to have an effect on the staging of osteosarcoma, while CCND1 (P=0.021), IRS2 (P=0.015), OLFML2B (P=0.035), CPE (P=0.037), MAMDC2 (P=0.044) and MMP13 (P=0.013) had an impact on the survival prognosis of osteosarcoma. Conclusions: IRS2 and 11 other genes differ from Ewing sarcoma and normal tissues, producing a specific expression on the staging or survival prognosis of osteosarcoma.
- 11 December 2023
- Published by Darcy & Roy Press Co. Ltd. in International Journal of Biology and Life Sciences
- Vol. 4 (2) , 7-13
Open AccessGenes Such as IRS2 Differ from Ewing Sarcoma and Normal Tissue-specific Expression for Osteosarcoma
Objective: To screen and validate the expression of other key genes specific to osteosarcoma that distinguish normal tissue from Ewing sarcoma using a bioinformatics approach. Methods: GSE73166 for osteosarcoma associated with Ewing sarcoma and GSE42352 for osteosarcoma associated with normal tissue were obtained from the GEO database, and these two datasets were screened for differential genes (DEGs) and subjected to corresponding GO enrichment and KEGG enrichment with GSEA validation, and then correlation analysis, PCA and immuno-infiltration analysis were performed on the two datasets, and the These two datasets were intersected to derive 28 differential genes, and the corresponding heat map analysis and protein interaction network analysis were performed for these 28 genes, and then the expression statistics of these 28 genes in GSE21257 for different graded genes and survival analysis in R2 for osteosarcoma in TARGET. Results: TNFRSF11B, COL12A1, PLOD2, PTGES, MEF2C, IRS2 and MMP13 were found to have an effect on the staging of osteosarcoma, while CCND1 (P=0.021), IRS2 (P=0.015), OLFML2B (P=0.035), CPE (P=0.037), MAMDC2 (P=0.044) and MMP13 (P=0.013) had an impact on the survival prognosis of osteosarcoma. Conclusions: IRS2 and 11 other genes differ from Ewing sarcoma and normal tissues, producing a specific expression on the staging or survival prognosis of osteosarcoma.